Fungal vaccines: real progress from real challenges

Area of Science:

• Mycology
• Immunology
• Vaccinology

Background:

• Fungal infections represent a significant global health burden.
• Unlike viral and bacterial diseases, no vaccines currently exist for fungal pathogens.
• Conventional treatments are often insufficient, especially in immunocompromised individuals.

Purpose of the Study:

• To review the current state and future prospects of fungal vaccine development.
• To highlight the challenges and advancements in creating immunological tools against fungal infections.

Main Methods:

• Review of recent literature on fungal pathogenesis and host-immune responses.
• Analysis of progress in genetic engineering, proteomics, and genome sequencing for vaccine design.
• Evaluation of preclinical and passive vaccination studies.

Main Results:

• Vaccine candidates are emerging that induce fungicidal antibodies.
• Protective immunity has been demonstrated in animal models with risk factors like CD4+ T-cell deficiency and neutropenia.
• Passive vaccination strategies using antibodies show promising efficacy.

Conclusions:

• Significant progress is being made in fungal vaccine research.
• Advances in host-fungus relations and technology are paving the way for new immunological interventions.
• There is growing optimism for the future availability of safe and effective fungal vaccines and therapies for vulnerable populations.